Weight Gain: A Possible Side Effect of All AntiretroviralsLucia Taramasso, Manfredi Mura, Elena Ricci et al.|Open Forum Infectious Diseases|2017Cited by 89
<p>The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile</p>Nicola Squillace, Paolo Bonfanti, Elena Ricci et al.|Drug Design Development and Therapy|2020Cited by 36
Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experienceMatteo Passerini, Giuliano Rizzardini, Monica Schiavini et al.|European Journal of Gastroenterology & Hepatology|2018Cited by 24
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individualsLucia Taramasso, Antonio Di Biagio, Giordano Madeddu et al.|Biomedicine & Pharmacotherapy|2014Cited by 8
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare.Nicola Squillace, Paolo Bonfanti, Barbara Menzaghi et al.|JHA - Journal of HIV and Ageing|2019Cited by 0